212 related articles for article (PubMed ID: 8801765)
1. Why prescribe highly purified factor VIII and IX concentrates?
Berntorp E
Vox Sang; 1996; 70(2):61-8. PubMed ID: 8801765
[TBL] [Abstract][Full Text] [Related]
2. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
3. [Transmission of hepatitis C by factor concentrates].
Aguilar C; Lucía JF
Sangre (Barc); 1996 Apr; 41(2):160-1. PubMed ID: 9045360
[No Abstract] [Full Text] [Related]
4. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
Mosley JW
Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
[TBL] [Abstract][Full Text] [Related]
5. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
[No Abstract] [Full Text] [Related]
6. Recombinant factor VIII in hemophilia A: the Canadian experience.
Blanchette VS
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
[TBL] [Abstract][Full Text] [Related]
7. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
McGrath KM; Thomas KB; Herrington RW; Turner PJ; Taylor L; Ekert H; Schiff P; Gust ID
Med J Aust; 1985 Jul; 143(1):11-3. PubMed ID: 2989666
[TBL] [Abstract][Full Text] [Related]
8. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
Heimburger N; Karges HE; Weidmann E
Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic properties and safety of recombinant factor VIII and factor IX.
Zdziarska J; Chojnowski K; Klukowska A; Łetowska M; Mital A; Podolak-Dawidziak M; Windyga J; Zawilska K;
Pol Arch Med Wewn; 2009 Jun; 119(6):403-9. PubMed ID: 19694223
[TBL] [Abstract][Full Text] [Related]
10. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
Maisonneuve P; Laurian Y; Guerois C; Verroust F; Ferrer Le Coeur F; Couroucé AM; Noel L
Nouv Rev Fr Hematol (1978); 1991; 33(3):263-6. PubMed ID: 1956764
[TBL] [Abstract][Full Text] [Related]
11. [Virus in hemophilia: current status and future perspectives].
Aguilar C; Félix Lucía J
Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
[No Abstract] [Full Text] [Related]
12. Safer factor VIII and IX.
Lancet; 1986 Aug; 2(8501):255-6. PubMed ID: 2874281
[No Abstract] [Full Text] [Related]
13. The choice of plasma-derived clotting factor concentrates.
Mannucci PM
Baillieres Clin Haematol; 1996 Jun; 9(2):273-90. PubMed ID: 8800505
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM
Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512
[TBL] [Abstract][Full Text] [Related]
15. Concentrate safety and efficacy.
Kasper CK
Haemophilia; 2002 May; 8(3):161-5. PubMed ID: 12010404
[TBL] [Abstract][Full Text] [Related]
16. Viral safety of plasma-derived factor VIII and IX concentrates.
Ludlam CA
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S19-23. PubMed ID: 9351532
[TBL] [Abstract][Full Text] [Related]
17. The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
Pierce GF; Lusher JM; Brownstein AP; Goldsmith JC; Kessler CM
JAMA; 1989 Jun; 261(23):3434-8. PubMed ID: 2498537
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C and pasteurised factor VIII and IX concentrates.
Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
[No Abstract] [Full Text] [Related]
19. Infection with hepatitis G virus among recipients of plasma products.
Jarvis LM; Davidson F; Hanley JP; Yap PL; Ludlam CA; Simmonds P
Lancet; 1996 Nov; 348(9038):1352-5. PubMed ID: 8918279
[TBL] [Abstract][Full Text] [Related]
20. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia].
Schimpf K
Behring Inst Mitt; 1983 Aug; (73):111-7. PubMed ID: 6433878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
